Pharmaceutical Contract Research Laboratory

Business Listing
REF: 541710-T12M17
EBITDA: Undisclosed
REVENUE: $2,766,585

Pharmaceutical Contract Research Laboratory

This Contract Research Organisation (CRO) is located in Canada with GLP bioanalytical, in vitro/in vivo DM/PK and CMC analytical chemistry capabilities with very dependable staff and well-established history of global clientele including biotech and pharmaceutical companies. Client base steadily returns with new business, year after year. Future growth potential to be realized with strategic buyer.


A strategic buyer could benefit from expanding their own operations with a complete laboratory and animal testing facility, and outsource services to a broader user base. Or sell extended services to the loyal user base that is already established, and generating solid financial returns. In 2015, CRO industry revenue was estimated at $25.6 billion.


The business has a diverse range of experienced and long-term employees who will be a part of the transition to new owners. The current owner of the Pharmaceutical Contract Research Laboratory is willing to remain in the business after the sale for up to one (1) year to ensure a smooth transition.


Approximately 6,000 sq. ft. bioanalytical laboratory space and a 3,000 sq. ft. adjacent animal facility.


2015 2016 2017 2018 (projected) 2019 (projected)
Revenue $ 1,642,411 1,566,308 2,766,585 2,960,246 3,256,271
Net Income $ 471,306 236,187 613,047 655,960 721,566

For full details on this listing please fill out the form below

Note: In order to find out specific details about this opportunity – please complete the buyer registration form, click this link